According to Race Oncology's latest financial reports the company's current EPS (TTM) is -0,03590 โฌ. In 2023 the company made an earnings per share (EPS) of -0,03590 โฌ an increase over its 2022 EPS that were of -0,04403 โฌ.
Year | EPS | Change |
---|---|---|
2023 | -0,03590 โฌ | -18.46% |
2022 | -0,04403 โฌ | 37.74% |
2021 | -0,03197 โฌ | 47% |
2020 | -0,02175 โฌ | -23.41% |
2019 | -0,02839 โฌ | -53.58% |
2018 | -0,06117 โฌ | 14.62% |
2017 | -0,05337 โฌ | 190.27% |
2016 | -0,01839 โฌ | |
2015 | N/A |